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ABSTRACT	  
Intrinsically	  disordered	  proteins	  are	  involved	  in	  many	  important	  cellular	  processes	  
such	  as	  the	  regulation	  of	  gene	  expression	  at	  the	  levels	  of	  transcription	  and	  translation,	  and	  
signal	   transduction.	   They	   are	   also	   involved	   in	   the	   regulation	   of	   cancerous	   and	  
neurodegenerative	  disease	  processes.	   Investigating	   the	  mechanism	  by	  which	   intrinsically	  
disordered	   proteins	   (IDPs)	   acquire	   structure	   upon	   binding	   to	   their	   specific	   partners	   is	  
technically	   challenging	   as	   the	   structural	   flexibility	   of	   IDPs	   limits	   the	   number	   of	   suitable	  
techniques.	  Circular	  dichroism	  (CD)	  spectroscopy	  coupled	  with	  osmotic	  stress	  was	  used	  to	  
measure	  the	  conformational	  changes	  of	  two	  IDPs	  separate	  from	  their	  mutual	  binding.	  The	  
disordered	  region	  of	  the	  CREB	  binding	  protein	  called	  NCBD	  and	  its	  binding	  partner	  ACTR	  
were	  used	  in	  this	  study.	  The	  osmotic	  stress	  applied	  by	  the	  presence	  of	  osmolytes	  revealed	  
information	  on	  the	  hydration	  changes	  and	  energetics	  that	  accompany	  folding.	  Overall,	  this	  
allows	   us	   to	   more	   closely	   discern	   the	   folding	   properties	   of	   these	   IDPs	   to	   uncover	   how	  
folding	  contributes	  toward	  binding.	  	  
	  
	   	  
BACKGROUND	  AND	  INTRODUCTION	  
Characteristics	  of	  Intrinsically	  Disordered	  Proteins	  and	  Their	  Biological	  Functions	  
Intrinsically	   disordered	   proteins	   (IDPs)	   lack	   a	   tertiary	   structure	   and	   exist	   in	   an	  
ensemble	   of	   states	   both	   in	   solution	   and	  when	  unbound	   to	   a	   ligand	   in	   vivo.	   They	   usually	  
have	  some	  local	  elements	  of	  secondary	  structure	  and	  some	  clusters	  of	  hydrophobic	  amino	  
acids	   (1).	   Despite	   the	   high	   degree	   of	   disorder,	   these	   proteins	   are	   far	   from	   randomly	  
structured	  and	  form	  transient,	  yet	  specific	  secondary	  and	  tertiary	  structural	  elements	  (2).	  
Intrinsically	   disordered	   proteins	   have	   prompted	   researchers	   to	   question	   the	  
structure-­‐function	  paradigm,	  which	  states	  that	  the	  three-­‐dimensional	  structure	  of	  a	  protein	  
determines	   its	  specific	   function	  (3,1).	   In	  fact,	  many	  proteins	  and	  domains	  within	  proteins	  
have	   been	   found	   to	   lack	   ordered	   globular	   structure	   in	   vivo	   and	   in	   solution.	   More	   than	  
15,000	  proteins	  in	  the	  Swiss	  Protein	  Database	  were	  found	  to	  contain	  disordered	  regions	  of	  
at	   least	   40	   consecutive	   amino	   acid	   residues	   (3).	   Furthermore,	   the	   occurrence	   of	  
unstructured	  regions	  of	  significant	  size	  (>50	  residues)	  is	  common	  in	  functional	  proteins	  (1).	  
Predictions	   on	   29	   genomes	   have	   established	   that	   intrinsic	   disorder	   is	   more	   common	   in	  
proteins	  from	  eukaryotes	  than	  in	  those	  from	  bacteria	  and	  archaea,	  with	  more	  than	  30%	  of	  
eukaryotic	  proteins	  having	  disordered	  regions	  greater	  than	  50	  consecutive	  residues	  (3).	  	  
The	   amino	   acid	   composition	   of	   intrinsically	   disordered	   proteins	   is	   distinguished	  
from	  those	  of	  structured	  proteins	  by	  certain	  features.	  	  These	  features	  include	  the	  presence	  
of	  numerous	  uncompensated	  charged	  groups,	  resulting	  in	  a	  large	  net	  charge	  at	  neutral	  pH	  
and	   a	   low	   content	   of	   hydrophobic	   amino	   acid	   residues	   (3).	   Specifically,	   amino	   acid	  
sequences	  particular	  to	  IDPs	  are	  characterized	  by	  the	  presence	  of	  low	  sequence	  complexity	  
and	  amino-­‐acid	  compositional	  bias,	  a	  low	  content	  of	  bulky	  hydrophobic	  amino	  acids	  which	  
would	  normally	  form	  the	  core	  of	  a	  folded	  globular	  protein	  (Val,	  Leu,	  Ile,	  Met,	  Phe,	  Trp,	  and	  
Tyr),	  and	  a	  high	  proportion	  of	  particular	  polar	  and	  charged	  amino	  acids	  (Gln,	  Ser,	  Pro,	  Glu,	  
Lys,	   and	   on	   occasion,	   Gly,	   and	  Ala)	   (1).	   This	   combination	   of	   the	   low	  hydrophobicity	   and	  
relatively	  high	  net	  charge	  is	  the	  characteristic	  of	  these	  proteins	  that	  contribute	  to	  their	  lack	  
of	  compact	  structure	  under	  physiological	  conditions	  (3).	  	  
Intrinsically	   disordered	   proteins	   are	   structurally	   adaptable	   and	   bind	   ligands	  
promiscuously,	  which	  means	  that	  they	  can	  adopt	  different	  conformations	  when	  they	  meet	  
different	   ligands	   (2).	   For	   example,	   the	   structure	   of	   NCBD	   in	   complex	  with	   IRF-­‐3	   has	   an	  
entirely	   different	   topology	   from	   its	   unbound	   conformation,	   both	   of	   which	   are	   different	  
from	   its	   structure	   in	   complex	   with	   ACTR.	   NMR	   data	   suggests	   that	   NCBD	   may	   sample	  
conformations	   other	   than	   its	   ACTR	   binding	   structure.	   The	   ability	   to	   sample	   different	  
conformations	  is	  facilitated	  by	  the	  low	  structural	  stability	  which	  allows	  the	  domain	  to	  have	  
sizeable	  populations	  of	  unfolded	  or	  partially	  folded	  states	  (2).	  	  
Many	   biological	   functions	   require	   the	   participation	   of	   intrinsically	   disordered	  
proteins.	  They	  function	  in	  the	  regulation	  of	  transcription	  and	  translation,	  regulation	  of	  the	  
cell	   cycle,	   cellular	   signal	   transduction,	   protein	   phosphorylation,	   the	   storage	   of	   small	  
molecules,	  and	  the	  regulation	  of	  the	  self-­‐assembly	  of	  large	  multiprotein	  complexes	  such	  as	  
the	   bacterial	   flagellum	   and	   the	   ribosome	   (1,2).	   Furthermore,	   IDPs	   that	   are	   involved	   in	  
signaling	   and	   transcription	   are	   relatively	   unstable	   and	   can	   be	   targeted	   for	   proteolytic	  
degradation	  through	  the	  ubiquitin-­‐proteasome	  system	  (1,2).	  They	  also	  function	  in	  protein-­‐
nucleic	   acid	   recognition	   as	  DNA-­‐binding	  proteins	   and	  RNA-­‐binding	  proteins.	   Intrinsically	  
disordered	  regions	  are	  also	  found	  in	  chaperones	  for	  other	  proteins	  and	  for	  RNA	  molecules,	  
in	   which	   capacity	   they	   bind	   to	   the	   misfolded	   proteins	   and	   RNA	   molecules	   and	   help	   to	  
unfold	  kinetically-­‐trapped	  folding	  intermediates	  (2).	  It	  is	  hypothesized	  that	  their	  structural	  
flexibility	  is	  what	  allows	  them	  to	  be	  suited	  for	  involvement	  in	  so	  many	  different	  regulatory	  
and	  signaling	  processes.	  
Characteristics	  of	  ACTR	  and	  NCBD	  and	  Their	  Biological	  Functions	  
The	   activator	   for	   thyroid	   hormone	   and	   retinoid	   receptors	   protein	   (ACTR)	   of	   the	  
p160	   nuclear	   receptor	   co-­‐activator	   is	   disordered	   in	   the	   free	   state,	   is	   a	   coactivator	   for	  
nuclear	   hormone	   receptors,	   and	   has	  multiple	   interaction	   domains	   (1,4).	   It	   directly	   binds	  
nuclear	   receptors	   and	   stimulates	   their	   transcriptional	   activities	   in	   a	   hormone-­‐dependent	  
fashion	   (4).	   It	   recruits	   two	   other	   nuclear	   factors,	   CBP	   and	   P/CAF,	   and	   thus	   serves	   as	   a	  
scaffold	   for	   creating	   a	   multisubunit	   coactivator	   complex.	   ACTR	   also	   is	   a	   histone	   acetyl-­‐
transferase	  (HAT)	  protein	  and	  plays	  an	  important	  role	  in	  hormonal	  signaling	  by	  acetylating	  
both	  free	  histones	  and	  nucleosome	  histones	  with	  substrate	  preference	  on	  histones	  H3	  and	  
H4	  (4).	  	  
Northern	   analysis	   showed	   that	   the	   mRNA	   level	   of	   ACTR	   was	   found	   in	   several	  
different	  human	  tissues	  and	  varied	  in	  its	  expression	  among	  them.	  Longer	  transcripts	  were	  
abundant	  in	  heart,	  skeletal	  muscle,	  pancreas,	  and	  placenta,	  relatively	  low	  in	  brain,	  very	  low	  
in	  lung	  and	  liver,	  and	  barely	  detectable	  in	  kidney	  (4).	  Shorter	  transcripts	  were	  also	  found	  in	  
different	  tissues	  at	  lower	  abundances	  (4).	  	  Human	  cancer	  cell	  lines	  examined	  also	  showed	  
restricted	  expression	  of	  ACTR	  mRNA	  (4).	  
The	  steroid	  receptor	  coactivator-­‐3	  (SRC-­‐3)	  is	  the	  homologue	  of	  ACTR	  in	  mouse.	  It	  is	  
a	  coactivator	  of	  nuclear	  receptors	  and	  is	  expressed	  in	  a	  tissue-­‐specific	  manner	  throughout	  
the	  oocytes,	  mammary	  glands,	  hippocampus,	  olfactory	  bulb,	   smooth	  muscle,	  hepatocytes,	  
and	   vaginal	   epithelium	   (5).	   Genetic	   disruption	   of	   SRC-­‐3	   in	   mice	   results	   in	   a	   pleiotropic	  
phenotype	  showing	  dwarfism,	  delayed	  puberty,	  reduced	  female	  reproductive	  function,	  and	  
blunted	  mammary	  gland	  development	  (5).	  Hormonal	  analysis	  indicates	  that	  SRC-­‐3	  plays	  a	  
role	   in	   both	   the	   growth	   hormone	   regulatory	   pathway	   and	   the	   production	   of	   estrogen,	  
which	  explains	  the	  mutant	  phenotypes	  observed	  when	  it	  is	  disrupted	  (5).	  	  
The	   cyclic-­‐AMP-­‐response-­‐element-­‐binding	   protein,	   (CREB)-­‐binding	   protein,	   or	  
(CBP),	  which	  contains	  the	  intrinsically	  disordered	  region	  NCBD,	  is	  a	  large	  nuclear	  protein	  
that	   enhances	   gene	   expression	   through	   the	   modification	   of	   histones	   in	   the	   process	   of	  
chromatin	  remodeling	  (1,6,7).	  Studies	  of	  steroid-­‐regulated	  gene	  promoters	  have	  revealed	  
that	  p160s	  and	  HAT	  proteins	  like	  CBP	  are	  among	  the	  first	  cofactors	  recruited	  in	  response	  to	  
ligand	  (6).	  Recruitment	  of	  coactivators	  to	  promoters/enhancers	  is	  crucial	  for	  the	  sequential	  
chromatin	  modification	  and	  remodeling	  events	  preceding	  transcription	  (6).	  Changes	  in	  the	  
chromatin	   structure	   are	   one	   of	   the	   ways	   in	   which	   gene	   expression	   is	   controlled.	  
Hyperacetylation	   of	   core	   histones	   is	   associated	   with	   gene	   activation	   at	   the	   level	   of	  
transcription	  while	  deacetylation	  is	  involved	  in	  gene	  repression	  (7).	  The	  recruitment	  of	  the	  
CREB-­‐binding	  protein	  (CBP)	  to	  target	  gene	  promoters/enhancers	  facilitates	  acetylation	  of	  
histone	  N-­‐terminal	   tails,	   leading	   to	   chromatin	   remodeling	  and	  enhanced	  gene	  expression	  
(6).	  This	  has	  been	  demonstrated	  for	  nuclear	  receptors,	  which	  activate	  transcription	  of	  their	  
target	   genes	   in	   response	   to	   ligand	   binding	   (6).	   Ligand	   bound	   receptors	   undergo	   a	  
conformational	   change	   that	   stimulates	   their	   interaction	   with	   cofactors	   that	   contain	  
functional	  LXXLL	  motifs,	  such	  as	  the	  p160	  coactivators	  SRC1,	  TIF2,	  and	  ACTR	  (6).	  	  
The	  CBP	  system	  exemplifies	  how	  the	  binding	  of	  intrinsically	  disordered	  proteins	  to	  
their	   targets	   is	   often	   regulated	   by	   covalent	   modifications	   that	   lead	   to	   simple	   biological	  
switches	   (1).	   CBP	   is	   a	   bridging	   protein	   that	   transmits	   the	   signal	   of	   ligand-­‐induced	  
conformation	  change	  to	  the	  basal	  transcriptional	  machinery	  (4).	  It	  modifies	  both	  chromatin	  
and	   transcription	   factors	   through	   its	   intrinsic	   acetyltransferase	   activity,	   and	   also	  
contributes	   to	   the	   scaffold	   for	   the	   recruitment	   and	   assembly	   of	   the	   transcriptional	  
machinery	   (1).	   	   It	   transmits	   the	   signal	   for	   the	   activation	   of	   transcription	   by	   nuclear	  
receptors,	   including	   CREB,	   AP-­‐1,	   and	   bHLH	   (7).	   Nuclear	   receptors	   are	   a	   large	   family	   of	  
ligand-­‐dependent	  transcription	  factors	  that	  bind	  as	  homodimers	  or	  heterodimers	  to	  their	  
cognate	  DNA	  elements	  and	  regulate	  genes	  involved	  in	  critical	  aspects	  of	  cell	  proliferation,	  
differentiation,	   and	   homeostasis	   (7).	   CBP	   plays	   a	   role	   in	   the	   control	   of	   cell	   growth	   and	  
differentiation	   by	   integrating	   signals	   for	   gene	   expression	   through	   interacting	   with	   the	  
transcription	  machinery	  and	  chromatin	  structure	  modification	  (7).	  	  
NCBD	  is	  the	  C-­‐terminal	  domain	  comprising	  residues	  2058-­‐2116	  of	  human	  CBP	  that	  
is	  responsible	  for	  the	  interaction	  of	  CBP	  with	  a	  number	  of	  other	  important	  proteins	  such	  as	  
the	  steroid	  receptor	  coactivators,	  interferon	  regulatory	  proteins,	  and	  the	  viral	  protein	  Tax	  
(1,2).	   In	   the	   ligand	   free	   state	   NCBD	   is	   compact	   and	   has	   a	   high	   degree	   of	   helicity,	   but	  
apparently	   it	   lacks	   sigmoidicity	   in	   the	   unfolding	   curve.	   These	   observations	   suggest	   that	  
NCBD	  is	  a	  molten	  globule	  (2).	  	  
While	  NCBD	  forms	  a	  molten	  globule	  with	  extensive	  tertiary	  interactions	  both	  in	  the	  
free	  and	   ligand	  bound	   states,	  ACTR	   is	   a	   random-­‐coil	   like	   IDP	   that	   folds	   into	  an	  extended	  
structure	   upon	   binding	   to	   its	   cognate	   ligands	   and	   has	   very	   few	   intramolecular,	   tertiary	  
interactions	  in	  the	  bound	  state	  (2).	  While	  an	  extended	  random	  coil	  structure	  is	  needed	  to	  
wrap	   around	   the	   binding	   partner,	   a	   molten	   globule	   ensemble	   of	   interconverting	   folded	  
structures	  provides	  a	  target	  for	  conformational	  selection	  by	  diverse	  ligands	  (2).	  	  	  
NCBD	   and	   ACTR	   fold	   upon	   mutually	   binding	   into	   a	   complex	   in	   a	   process	   called	  
mutual	  synergistic	  folding	  (1,2).	  Unlike	  the	  well	  ordered	  TAZ	  and	  KIX	  domains	  of	  CBP,	  the	  
NCBD	  resembles	  a	  highly	  helical	  molten	  globule	  more	  than	  a	  stably	  folded	  protein	  (1).	  The	  
NCBD	   has	   an	   amino-­‐acid	   composition	   that	   would	   be	   expected	   for	   an	   intrinsically	  
disordered	  protein.	  It	  is	  highly	  enriched	  in	  Gln,	  Pro,	  Ser,	  and	  Leu	  residues,	  and	  cannot	  bury	  
enough	  of	  its	  hydrophobic	  surface	  to	  form	  a	  stable	  globular	  structure	  in	  the	  absence	  of	  its	  
binding	   partner	   (1).	   This	   is	   reinforced	   by	   the	   denaturation	   behavior	   of	   isolated	   NCBD,	  
which	   shows	   neither	   the	   sigmoidal	   unfolding	   curve	   nor	   the	   characteristic	   heat	   capacity	  
change	  that	  accompany	  the	  unfolding	  of	  a	  globular	  protein	  (1).	  
Studying	  the	  IDPs	  ACTR	  and	  NCBD	  
The	   discovery	   of	   so	   many	   unstructured	   proteins	   and	   regions	   within	   proteins	   is	  
recent	  and	  can	  be	  ascribed	   to	   the	  availability	  of	   large	  amounts	  of	   sequence	  data	   coupled	  
with	   gene	   based	   functional	   analysis,	   and	   to	   spectroscopic	   techniques	   that	   have	   been	  
developed	  to	  analyze	  their	  structural	  properties	  in	  solution	  (1).	  Crystal-­‐structure	  analysis	  
is	  useful	  for	  indicating	  the	  presence	  of	  unstructured	  states	  in	  a	  protein,	  but	  cannot	  provide	  
structural	  information	  about	  these	  unstructured	  states	  (1).	  Instead,	  spectroscopic	  methods	  
including	   NMR	   and	   CD	   spectroscopy,	   among	   others,	   are	   commonly	   used	   to	   study	   the	  
dynamics	  of	  disordered	  proteins	  (1).	  	  	  
In	  order	   to	   investigate	   the	  structural	  changes	  of	  NCBD	  and	  ACTR	  before	  and	  upon	  
binding,	   the	   CD	   signal	   was	   measured	   as	   increasing	   osmotic	   stress	   was	   applied	   to	   the	  
peptides	   in	   solution.	   It	  was	   hypothesized	   that	   increased	   osmotic	   pressure	  would	   induce	  
protein	  folding	  by	  effecting	  a	  transition	  from	  random	  coil	  to	  α-­‐helix	  in	  unbound	  ACTR	  and	  
NCBD	  as	  measured	  by	  CD	  spectroscopy.	  The	  CD-­‐signal	  at	  200nm	  was	  used	  as	  an	  indicator	  
of	  random	  coil,	  while	   the	  signal	  at	  222nm	  was	  used	  as	  an	   indicator	  of	  α-­‐helix.	   Increasing	  
negativity	   in	   the	   signal	   at	   222nm	   means	   that	   the	   protein	   contains	   more	   α-­‐helix,	   while	  
increasing	  positivity	   in	   the	  signal	  at	  200nm	  means	   that	   the	  protein	  contains	   less	  random	  
coil.	  	  
This	  technique	  is	  relevant	  to	  the	  environment	  inside	  living	  cells,	  as	  small	  cosolutes	  
called	   osmolytes	   are	   used	   to	   counteract	   external	   osmotic	   pressure	   that	  would	   otherwise	  
cause	   proteins	   to	   misfold.	   Osmolytes	   protect	   proteins	   by	   stabilizing	   their	   native	  
conformations,	   and	   are	   excluded	   from	   protein-­‐water	   interfaces	   (8).	   However,	   the	   exact	  
mechanism	  by	  which	  osmolytes	  stabilize	  macromolecules	  is	  not	  fully	  understood	  (8).	  
One	   possible	   mechanism	   by	   which	   osmolytes	   stabilize	   proteins	   is	   molecular	  
crowding	   due	   to	   excluded	   volume	   interactions.	   It	   has	   been	   demonstrated	   that	   a	   high	  
fractional	   volume	   occupancy	   of	   crowding	   agents,	   such	   as	   soluble	   polymers,	   significantly	  
shifts	   the	   non-­‐native	   to	   folded	   thermodynamic	   equilibrium	   (DßàN)	   toward	   the	   more	  
compact	   native	   states	   (8).	   This	   effect	   is	   associated	   with	   the	   restriction	   of	   protein	  
conformations	   to	   allow	   larger	   free	   volume	   for	   osmolytes,	   thereby	   destabilizing	   the	  
unfolded	  state	  with	  respect	  to	  the	  native	  conformation	  (8).	  	  
MATERIALS	  AND	  METHODS	  
Materials 
The	  nuclear	  receptor	  coactivator	  binding	  domain	  (NCBD)	  of	  mouse	  cAMP	  response	  
element	   binding	   (CREB)	   protein	   (CBP,	   accession:	   NP_001020603),	   CBP(2059-­‐2117)	   (59	  
residues,	  6545	  Da),	  and	  the	  interaction	  domain	  of	  mouse	  activator	  for	  thyroid	  hormone	  and	  
retinoid	   receptor	   (ACTR,	   accession:	   o09000),	   ACTR(1025-­‐1098)	   (74	   residues,	   7989	   Da),	  
were	  synthesized	  by	  solid-­‐phase	  FMOC	  chemistry	  (Keck-­‐Yale	  facility).	  The	  crude	  peptides	  
were	  purified	  by	  high	  performance	   liquid	   chromatography	  using	   a	  Zorbax	  SB-­‐C3	   column	  
(Agilent	  Technologies)	  with	  a	  reverse	  phase	  water	  (+	  0.05%	  TFA)	  /	  acetonitrile	  (+	  0.05%	  
TFA)	  gradient	  and	   lyophilized.	  Fractions	  were	  collected	   in	  100	  x	  13	  mm	  disposable	  glass	  
tubes.	   Mass	   spectrometry	   confirmed	   the	   molecular	   mass	   of	   the	   peptides.	   Phosphate	  
buffered	  saline	  (PBS,	  20X),	  TFA,	  and	  ethylene	  glycol,	  triethylene	  glycol	  polyethylene	  glycol	  
400,	  betaine,	  and	  xylitol	  were	  used	  without	  further	  purification.	  	  
Purification and Preparation of Peptide Samples 
The	  peptide	  samples	  (ACTR	  and	  NCBD)	  were	  prepared	  for	  CD	  spectroscopy	  by	  HPLC	  
purification.	  The	  frozen	  peptides	  were	  allowed	  to	  come	  to	  room	  temperature	  and	  then	  re-­‐
suspended	  in	  1%(wt)	  TFA	  until	  dissolved	  completely,	  and	  then	  centrifuged	  for	  8	  minutes	  at	  
high	   speed	   to	   collect	   insoluble	   impurities	   in	   a	  pellet	   at	   the	  bottom.	  The	   supernatant	  was	  
removed	   and	   the	   pellet	   containing	   resins,	   impurities,	   and	   contaminants	   was	   allowed	   to	  
remain	  behind.	  The	  supernatant	  was	  injected	  onto	  the	  HPLC	  column.	  	  
The	  peptide	   fractions	  corresponding	  to	  the	  215	  nm	  absorbance	  peak	  on	  the	  graph	  
produced	  by	  the	  BioLogic	  DuoFlow	  software	  were	  collected	  and	  combined.	  A	  35	  µL	  sample	  
was	   taken	   from	  the	  combined	   fractions	   for	  analysis	  by	   the	  analytic	  HPLC.	  The	  remainder	  
was	  lyophilized	  and	  frozen	  for	  use	  in	  the	  CD	  experiments.	  	  
The	  yields	  of	  the	  peptides	  after	  purification	  were	  calculated	  according	  to	  the	  linear	  
fit	   from	  a	   standard	  curve	  made	   for	   the	  ACTR	  peptide.	  These	   linear	   fits	  of	   these	   standard	  
curves	  were:	  	  
Area	  =	  (866.16	  ±	  4.81)	  x	  (ug	  ACTR)	  
Area	  =	  (1440)	  x	  (ug	  NCBD)	  
A	  35	  µL	  sample	  was	   taken	   from	  each	   tube	  of	   combined	   fractions	  and	  analyzed	  by	  
analytical	  HPLC.	  The	  HPLC	  produced	  a	  graph	  which	  had	  mAU	  on	  the	  y	  axis	  and	  minutes	  on	  
the	  x	  axis.	  The	  area	  under	  the	  curve	  on	  a	  graph	  of	  mAU	  vs.	  time	  (minutes)	  corresponding	  to	  
the	  peptide	  was	  taken	  and	  used	  in	  the	  following	  calculation:	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The	  amount	  of	  crude	  peptide	  used	  in	  the	  calculation	  was	  adjusted	  for	  the	  volume	  of	  
the	  peptide	  that	  was	  actually	  injected	  onto	  the	  HPLC.	  Only	  0.9	  mL	  of	  the	  1.1	  mL	  volume	  of	  
the	  peptide	  was	  dissolved	  in	  were	  actually	  injected.	  The	  yields	  were	  very	  low	  and	  ranged	  
for	   NCBD	   from	   2.57	   to	   4.03%,	   and	   for	   ACTR	   from	   3.89	   to	   6.62%.	   The	   solvent	   that	   was	  
chosen	  to	  dissolve	  the	  crude	  peptide	  may	  in	  part	  explain	  these	  low	  yields.	  Indeed,	  the	  1%	  
TFA	  solution	  might	  not	  have	  been	  strong	  enough	  to	   fully	  dissolve	  the	  peptide,	  and	  so	  the	  
pellet	  that	  was	  observed	  in	  the	  bottom	  of	  the	  tube	  after	  centrifugation	  likely	  contained	  not	  
only	  impurities	  like	  resins	  but	  also	  insolubilized	  peptide.	  One	  possible	  option	  would	  have	  
been	  to	  use	  formic	  acid	  instead,	  with	  the	  caution	  to	  not	  allow	  it	  to	  come	  into	  contact	  with	  
the	   peptide	   for	   more	   than	   30	   minutes	   in	   order	   to	   avoid	   formylation	   of	   the	   methionine	  
residues.	  	  
Circular	  Dichroism	  Spectroscopy	  
CD	   spectra	   were	   collected	   with	   an	   Olis	   RSM	   1000	   circular	   dichroism	  
spectrophotomer	   using	   the	   Olis	   spectralWorks	   software	   (Bogart,	   GA).	  Wavelength	   scans	  
from	  260	  to	  190	  nm	  were	  performed	  with	  1	  nm	  steps	  and	  integration	  time	  per	  data	  point	  
determined	  automatically	  as	  a	  function	  of	  PMT	  voltage.	  All	  CD	  experiments	  were	  conducted	  
at	  22°C.	  
Two	  vials	  of	   lyophilized	  peptide	  were	  combined	  and	  dissolved	   into	  0.75	  mL	  of	  2X	  
PBS	   so	   that	   final	   concentrations	   in	   1X	   PBS	  would	   be	   in	   the	   range	   of	   0.2-­‐0.4	  mg/mL,	   the	  
concentration	  needed	  to	  elicit	  a	  CD	  signal.	  Exact	  peptide	  concentrations	  were	  determined	  
by	  HPLC	  using	  a	  standard	  curve	  generated	  from	  amino	  acid	  analysis	  (AlbioTech,	  Richmond,	  
VA).	   Two	   solutions	   were	   then	   made:	   one	   was	   a	   solution	   without	   any	   osmolyte,	   which	  
consisted	  of	  0.35	  mL	  of	  the	  peptide	  2X	  PBS	  solution	  +	  0.35	  mL	  of	  H2O.	  The	  second	  solution	  
was	   the	   highest	   concentration	   osmolyte	   solution,	   which	   had	   0.35	   mL	   peptide	   2X	   PBS	  
solution	  +	  0.35	  ml	  80	  wt%	  osmolyte	  in	  water	  (for	  EG,	  TEG,	  and	  PEG	  400).	  Serial	  dilutions	  
were	  made	  from	  these	  two	  solutions.	  To	  measure	  CD	  of	  each	  sample,	  320	  uL	  was	  put	  into	  a	  
1mm	  quartz	  cell.	  The	  weight	  percents	  that	  were	  tested	  for	  EG,	  TEG,	  and	  PEG400	  were	  0%,	  
5%,	  10%,	  17.5%,	  25%,	  30%,	  and	  40%.	  For	  xylitol,	  the	  molalities	  that	  were	  tested	  included	  
1.0m,	   1.75m	   	   2.5m,	   3.0m,	   and	   4.0m.	   For	   betaine,	   the	   molalities	   were	   0m,	   0.25m,	   0.5m,	  
1.25m,	  1.5m,	  and	  2.0m.	  	  
First,	   background	   scans	   of	   all	   the	   solutions	   of	   varying	   osmolyte	   concentration	   in	  
percent	   by	   weight	   were	   taken	   so	   their	   CD	   signals	   could	   be	   subtracted	   from	   the	  
corresponding	  CD	  signals	  of	  the	  solutions	  that	  included	  the	  peptides.	  
Next,	  a	  1:1	  molar	  ratio	  of	  NCBD:ACTR	  in	  2X	  PBS	  was	  prepared	  from	  the	  individual	  
peptide	   solutions	   to	  yield	  NCBD/ACTR	  dimer.	  To	  do	   this,	   first	   the	  molarities	  of	   a	   sample	  
each	  of	  ACTR	  and	  of	  NCBD	  were	  calculated.	  	  
For	  ACTR:	  !.!!""  !" ∙ !"#
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The	  tubes	  containing	  the	  ACTR	  and	  the	  NCBD	  were	  each	  resuspended	  in	  0.360	  mL	  of	  
2X	  PBS.	  Since	   the	   two	  molecules	  bind	   in	  a	  1:1	   ratio,	  NCBD	   in	   this	   case	   is	  kind	  of	   like	   the	  
limiting	  reagent	   in	  a	  chemical	  reaction.	  To	  obtain	  !.!"# ∙ !"!!!"#	  of	  ACTR	  to	  react	  with	  





= !.!"#  !"	  
Then	  0.279	  mL	  of	  the	  ACTR	  solution	  made	  as	  described	  above	  were	  added	  into	  the	  
tube	  containing	  the	  0.36	  mL	  of	  NCBD	  to	  produce	  a	  solution	  that	  was	  0.639	  mL	  in	  volume.	  
This	  0.630	  mL	  of	  solution	  was	  diluted	  with	  0.111	  mL	  of	  2X	  PBS	  to	  get	  0.750	  mL	  of	  peptide-­‐
containing	  solution	  that	  was	  needed	  for	  the	  dilution	  scheme.	  	  
The	   concentration	   of	   the	   solution	   was	   calculated.	   At	   this	   point,	   the	   solution	  
contained	  1.187 ∙ 10!!	  mol	  of	  the	  ACTR/NCBD	  complex.	  The	  molar	  mass	  of	  the	  complex	  is	  
!"#$" !
!"#




The	   concentration	   of	   the	   solution	   containing	   NCBD/ACTR	   was	   !.!"#$!%  !"
!.!"#  !"
=
  !.!"#  !"  !"!!,	  which	  was	  in	  the	  0.2-­‐0.4	  mg	  mL-­‐1	  range	  required	  in	  the	  experiments	  in	  
which	  ACTR	  and	  NCBD	  were	  studied	  separately.	  	  
Samples	  were	   loaded	   into	  a	  1	  mm	  pathlength	  quartz	   cuvette.	  The	  CD	  spectrum	  of	  
the	   2X	   PBS	   buffer	   solution	   was	   subtracted	   from	   the	   sample	   spectra.	   These	   background	  
subtracted	  CD	  spectra	  were	  converted	  to	  units	  of	  mean	  residue	  ellipticity,	   [θ]	  =	   [deg	  cm2	  
dmol-­‐1].	   The	   additive	  molecular	  mass	   and	   number	   of	   residues	   for	  NCBD	   and	  ACTR	  were	  
used	  to	  normalize	  the	  NCBD/ACTR	  signal	  to	  [θ].	  	  
	   The	  mean	  residue	  ellipticity	  adjustment	  of	  the	  CD	  signal	  is	  based	  on	  the	  fact	  that	  the	  
light	  source	  in	  the	  spectrometer	  traces	  out	  an	  ellipse,	  and	  as	  a	  result	  the	  light	  is	  elliptically	  
polarized	   (9).	   Elliptically	   polarized	   light	   can	   be	   resolved	   into	   left	   and	   right-­‐circularly	  
polarized	   components,	   which	   are	   absorbed	   unequally	   through	   an	   optically	   active	   or	  
chiroptical	  absorption	  band	  (9).	  Thus	  CD	  can	  be	  expressed	  in	  two	  ways,	  one	  of	  which	  is	  to	  
measure	  the	  ellipticity.	  The	  ratio	  of	  the	  minor	  axis	  to	  the	  major	  axis	  of	  the	  ellipse	  defines	  
the	  tangent	  of	  ellipticity	  (9).	  Because	  the	  difference	  in	  absorbances	  of	  the	  two	  components	  
is	  only	  a	  small	  fraction	  of	  the	  average	  absorbance,	  the	  ellipse	  is	  extremely	  elongated.	  Thus,	  
tangent	  (ellipticity)	  can	  be	  approximated	  as	  ellipticity.	  For	  macromolecules	  the	  CD	  data	  are	  
expressed	   in	   mean	   residue	   ellipticities	   [θ],	   rather	   than	   molar	   absorption	   coefficients,	  
!! − !!.	   These	   quantities	   are	   independent	   of	   the	   relative	   molecular	   mass	   (or	   molecular	  
weight)	   of	   the	   biopolymer,	   unless	   the	   conformation	   of,	   say,	   oligomers	   of	   α-­‐helical	  
polypeptides	  depends	  on	  the	  degree	  of	  polymerization.	  Traditionally,	  CD	  can	  be	  calculated	  





or	   ! = !""# !" ,	  
where	  the	  As	  are	  absorbances,	  l	  and	  l’	  are	  the	  light	  path	  in	  cm	  and	  dm,	  respectively,	  M0	  is	  
the	  mean	  residue	  weight	  (about	  115	  for	  proteins),	  c	  is	  the	  concentration	  in	  g/cm3,	  and	  m	  is	  
the	   mean	   residue	   molar	   concentration.	   The	   two	   quantities	   are	   related	   by	   a	   conversion	  
factor	  of	  3300	  (Yang,	  1969):	   ! = !"""(!! − !!).	  The	  dimensions	  of	   ! 	  and	  (!! − !!)	  are	  
deg	  cm2	  dmole-­‐1	  and	  M-­‐1cm-­‐1,	  respectively	  (9).	  
A	  plot	  of	   ! 	  (deg	  cm2	  dmole-­‐1)	  vs.	  wavelength	  (nm)	  was	  made	   for	  all	   the	  different	  
osmolytes.	  Then,	  a	  plot	  of	   ! !!!	  (deg	  cm2	  dmole-­‐1)	  	  vs.	  OsmP	  (mmol	  kg-­‐1)	  was	  also	  made	  for	  
all	   the	   different	   osmolytes.	   It	   was	   necessary	   to	   find	   the	   fraction	   of	   helix	   in	   the	   peptide	  




(10).	  However	  in	  NCBD	  and	  ACTR,	  not	  all	  of	  the	  residues	  can	  adopt	  an	  α-­‐helix	  structure,	  so	  
the	   following	  modified	  equation	   is	  used:	  !! =   
!"#!"#$%&"'!!"#!"#
!"#!"#!!"#!"#
.	   	  As	   calculated	   from	  the	  
NMR	  structure	  of	  NCBD/ACTR	  complex	  (1KBH.pbd),	  in	  the	  bound	  state	  NCBD	  has	  61%	  α-­‐
helix	  and	  ACTR	  has	  38%	  α-­‐helix.	  Thus	  the	  maximum	  helical	  content	  for	  each	  will	  yield	  a	  CD	  
signal,	  MRE	  of	  the	  following:	  
! !!!(!"#$,!"#!"#$%) = − !.!" ∗ !"###− !""" = !"#$"	  
! !!!(!"#$,!"#!"#$%) = − !.!" ∗ !"###− !""" = !!"#$	  
From	   ! !!! 	  deg	   cm2	   dmole-­‐1,	   the	   fraction	   of	   α-­‐helix	   for	   each	   peptide	   and	   osmolyte	  
condition	  was	  calculated	  according	  to	  !! =   
[!]!!!!!"""
!!!"#$!!"""








Next,	  the	  natural	  logarithm	  of	  the	  equilibrium	  constant	  for	  folding	  for	  each	  peptide	  
in	  each	  osmolyte	  condition	  was	  calculated,	  as	  in	  !"!!" = !"  (
!!
!!!!
),	  and	  substituted	  into	  the	  
expression	   for	  ΔΔ! 	  for	   each	   peptide/osmolyte	   condition,	   which	   is	  !!" =   −!.!"#$ ∗
!"#.!" ∗ !"!!" − !"!!",!.	  	  
Using	  ΔΔ! 	  ,	   the	   number	   of	   waters	   released	   from	   upon	   folding	   was	   calculated	  







	  where	  !! 	  is	  the	  chemical	  potential	  of	  water,	  55.6	  is	  
the	   number	   of	   moles	   of	   water	   in	   1	   kg,	   and	   [Osm]	   represents	   the	   solute	   osmolal	  
concentration,	  a	  measure	  of	  water	  chemical	  potential	  (8).	  	  
Vapor	  pressure	  osmometry	  was	  used	  to	  measure	  the	  vapor	  pressure	  of	  the	  samples,	  
however,	  for	  many	  of	  the	  osmolytes,	  including	  TEG	  and	  PEG	  400,	  the	  instrument	  wouldn’t	  
measure	   past	   3500	  mmol/kg,	   and	   the	   vapor	   pressure	   of	   the	   30	  wt%	   TEG	   exceeded	   the	  
capacity	  of	  the	  osmometer,	  so	  calculated	  osmotic	  pressures	  were	  used	  instead.	  	  
RESULTS	  AND	  DISCUSSION	  	  
Describing	  ACTR	  and	  NCBD	  
The	  peptides	  that	  were	  used	  in	  this	  study	  were	  ACTR	  (activator	  for	  thyroid	  hormone	  
and	   retinoid	   receptor),	   74	   residues,	   and	   NCBD	   (nuclear	   receptor	   coactivator	   binding	  
domain),	  59	   residues.	  Table	  1	   shows	   the	  percentages	  of	   secondary	   structure	  elements	   in	  
ACTR	  and	  NCBD	   in	   the	  bound	  and	  unbound	  states.	  NCBD	  has	   twice	   the	  percentage	  of	  α-­‐
helix	  in	  the	  unbound	  state	  as	  does	  ACTR.	  The	  actual	  CD	  signal	  at	  222	  is	  more	  negative	  for	  
the	  complex	  than	  the	  prediction	  represented	  by	  the	  gray	  curve	  in	  Figure	  1.	  When	  these	  two	  
peptides	   bind,	   an	   increase	   occurs	   in	   the	   total	   α-­‐helical	   content	   over	   what	   would	   be	  
expected	   in	   the	   absence	   of	   structural	   changes,	   which	   indicates	   that	   they	   experience	  
secondary	  structure	  changes	  upon	  binding.	  	  
Table	  1.	  This	  chart	  displays	   the	  percentages	  of	   the	  different	   types	  of	  secondary	  structure	  
elements	  in	  the	  unbound	  and	  bound	  forms	  of	  NCBD	  and	  ACTR,	  as	  well	  as	  the	  percentages	  





Figure	   1.	   Circular	   dichroism	   (CD)	   spectra	   of	   NCBD	   (¡),	   ACTR	   (r),	   and	   NCBD/ACTR	  
complex	   (¨)	   with	   the	   corresponding	   secondary	   structure	   fits	   (solid	   black	   lines).	   NCBD	  
(58.1	   mM),	   ACTR	   (51.3	   mM),	   and	   NCBD/ACTR	   (27.2	   mM)	   were	   in	   1X	   TBS	   buffer.	   The	  
calculated	   CD	   spectrum	   for	   a	   50:50	   mixture	   of	   NCBD	   and	   ACTR	   from	   the	   respective	  
individual	  spectra,	  which	  assumes	  no	  interactions	  or	  changes	  in	  their	  secondary	  structure,	  
is	   shown	   (solid	   grey	   line)	   for	   comparison.	   The	  more	   pronounced	   negative	   peak	   around	  
222nm	   for	   the	   experimentally	  measured	  NCBD/ACTR	   is	   indicative	   of	   increased	   a-­‐helical	  
content	  from	  the	  binding	  interaction	  between	  NCBD	  and	  ACTR.	  	  
	  
CD	  on	  NCBD,	  ACTR,	  and	  NCBD/ACTR	  with	  Osmolytes	  
As	   the	   weight	   percent	   of	   PEG400	   increases,	   ! !!!	  becomes	   more	   negative	   while	  
! !""	  becomes	   more	   positive.	   The	   signal	   at	   222nm	   is	   an	   indicator	   of	  α-­‐helix	   while	   the	  
signal	  at	  200	  nm	  is	  an	  indicator	  of	  random	  coil.	  This	  effect	  is	  seen	  for	  ACTR	  (Fig.2),	  NCBD	  





























in	  the	  protein	  in	  solutions	  containing	  higher	  concentrations	  of	  osmolyte	  than	  in	  solutions	  
containing	  less.	  At	  40%	  (v/v)	  of	  PEG	  400,	  the	  percentage	  of	  α-­‐helix	  is	  significantly	  closer	  to	  
the	   percentage	   of	  α-­‐helix	   in	   the	   folded	   protein	   than	   at	   0%.	   The	   percentage	   of	   α-­‐helix	   in	  
ACTR	  relative	   to	   the	  percentage	   in	   the	  bound	  state	   increases	   from	  19%	  to	  71%	  between	  
0%	  (v/v)	  of	  PEG	  400	  and	  40%.	   	  For	  NCBD,	  the	   increase	   is	   from	  40%	  to	  85%,	  and	  for	  the	  
complex,	  from	  100%	  to	  114%.	  Thus,	  increased	  osmolyte	  concentration	  effected	  a	  change	  in	  
secondary	  structure	  in	  NCBD	  and	  ACTR	  separately	  and	  when	  bound.	  It	  is	  significant	  that	  an	  
increase	  in	  folding	  was	  observed	  in	  the	  complex,	  in	  which	  ACTR	  and	  NCBD	  are	  represented	  
as	  already	  having	  reached	  100%	  of	  their	  α-­‐helical	  content.	  
Figures	   5,	   6,	   and	   7	   display	   the	   relationship	   between	   the	   signal	   at	   222nm	   and	   the	  
osmotic	   pressure	   in	   osmolality	   for	   ACTR,	   NCBD,	   and	   NCBD/ACTR	   in	   PEG400.	   Osmotic	  
pressure	  is	  proportional	  to	  the	  weight	  percent,	  and	  as	  expected,	  the	  signal	  becomes	  more	  
negative	  as	   the	  osmotic	  pressure	   increases,	   indicating	   that	  more	  α-­‐helix	   is	  present	   in	   the	  
peptide	   at	   higher	   osmotic	   pressures.	   Figures	   5,	   6,	   and	   7	   are	   like	   taking	   a	   slice	   through	  
figures	  2,	  3,	  and	  4	  at	  the	  wavelength	  of	  222	  nm.	  A	  similar	  slice	  taken	  at	  200	  nm	  would	  show	  
an	   increase	   in	   the	   in	   the	   CD	   signal	   with	   weight	   percent,	   indicating	   a	   corresponding	  
decrease	  in	  the	  random	  coil	  content	  of	  the	  peptide.	  	  	  
	  
Figure	   2.	   ACTR	   in	   PEG	   400.	   Mean	   residue	   ellipticity	   as	   a	   function	   of	   the	   wavelength	   of	  
circularly	   polarized	   light	   for	   solutions	   containing	   ACTR	   and	   PEG	   400.	   CD	   indicates	   that	  
ACTR	   initially	   contains	   18%	   α-­‐helix	   without	   added	   osmolyte.	   As	   the	   osmolyte	  
concentration	   in	   solution	   increases	   from	  0-­‐40%	   (v/v),	   the	  CD	   signal	   at	   222	  nm	  becomes	  
increasingly	   negative,	   indicating	   that	   the	   peptide	   adopts	   more	   α-­‐helical	   structure.	  
Calculations	   from	  the	  NMR	  structure	  show	  that	  ACTR	  contains	  38%	  α-­‐helix	   in	   the	  bound	  

















































Figure	   3.	   NCBD	   in	   PEG	   400.	   Mean	   residue	   ellipticity	   as	   a	   function	   of	   the	   wavelength	   of	  
circularly	   polarized	   light	   for	   solutions	   containing	   NCBD	   and	   PEG	   400.	   CD	   indicates	   that	  
NCBD	   initially	   contains	   40%	   α-­‐helix	   without	   added	   osmolyte.	   As	   the	   osmolyte	  
concentration	   in	   solution	   increases	   from	  0-­‐40%	   (v/v),	   the	  CD	   signal	   at	   222	  nm	  becomes	  
increasingly	   negative,	   indicating	   that	   the	   peptide	   adopts	   more	   α-­‐helical	   structure.	  
Calculations	   from	  the	  NMR	  structure	  show	  that	  NCBD	  contains	  61%	  α-­‐helix	   in	  the	  bound	  
state.	  At	  40%	  (v/v)	  of	  PEG	  400,	  NCBD	  achieved	  88%	  of	  the	  bound	  state	  α-­‐helicity.	  	  
	  
	  
Figure	  4.	  NCBD/ACTR	  in	  PEG400.	  Mean	  residue	  ellipticity	  as	  a	  function	  of	  the	  wavelength	  
of	  circularly	  polarized	  light	  for	  solutions	  containing	  NCBD/ACTR	  and	  PEG	  400.	  CD	  indicates	  
that	  NCBD/ACTR	  initially	  contains	  38%	  α-­‐helix	  without	  added	  osmolyte.	  As	  the	  osmolyte	  
concentration	   in	   solution	   increases	   from	  0-­‐40%	   (v/v),	   the	  CD	   signal	   at	   222	  nm	  becomes	  
increasingly	   negative,	   indicating	   that	   the	   peptide	   adopts	   more	   α-­‐helical	   structure.	  
Calculations	   from	  the	  NMR	  structure	  show	  that	  NCBD/ACTR	  contains	  48%	  α-­‐helix	   in	   the	  





















Figure	  5.	  This	  graph	  shows	  mean	  residue	  ellipticity   ! !!!(deg cm! dmole!!)as	  a	   function	  
of	  osmotic	  pressure	  for	  ACTR	  in	  PEG400.	  The	  increasing	  negativity	  of	  the	  signal	  at	  222	  nm	  
indicates	  that	  there	  is	  more	  α-­‐helix	  present	  as	  the	  osmotic	  pressure	  increases.	  	  
 
 
Figure	  6.	  This	  graph	  shows	  mean	  residue	  ellipticity	   ! !!!(deg cm! dmole!!)  as	  a	  function	  
of	  osmotic	  pressure	  for	  NCBD	  in	  PEG400.	  The	  increasing	  negativity	  of	  the	  signal	  at	  222	  nm	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Figure	  7.	  This	  graph	  shows	  mean	  residue	  ellipticity	   ! !!!(deg cm! dmole!!)  as	  a	  function	  
of	  osmotic	  pressure	  for	  NCBD/ACTR	  in	  PEG400.	  The	  increasing	  negativity	  of	  the	  signal	  at	  
222	  nm	  indicates	  that	  there	  is	  more	  α-­‐helix	  present	  as	  the	  osmotic	  pressure	  increases.	  
Thermodynamics	  of	  osmolyte-­‐induced	  folding	  of	  ACTR,	  NCBD,	  and	  NCBD/ACTR	  
The	   osmotic	   stress	   technique	   used	   to	   induce	   folding	   is	   relevant	   to	   the	   in	   vivo	  
environment	  in	  which	  IDPs	  are	  found.	  The	  intracellular	  environment	  is	  crowded	  with	  salts,	  
sugars,	   amino	   acids,	   macromolecules	   like	   DNA	   and	   proteins.	   Thus,	   this	   intracellular	  
environment	  differs	  from	  the	  dilute	  aqueous	  conditions	  that	  are	  usually	  used	  in	  enzymatic,	  
molecular	  recognition,	  and	  protein	  biomolecular	  assembly	  reactions	  (11).	  Protein	  stability	  
and	  activity	  vary	  according	  to	  variances	  including	  hydration	  levels,	  ion	  concentrations	  and	  
pH,	  among	  other	  solvent	  conditions.	  Cells	  strive	  to	  maintain	  proteins’	  shapes	  and	  functions	  
in	   the	   face	   of	   environmental	   stress	   by	   accumulating	   osmolytes	   which	   most	   commonly	  
include	   polyols,	   amino	   acids,	   and	   combinations	   of	   methylamines	   with	   urea	   (12).	   These	  
protective	  osmolytes	  shift	  the	  thermodynamic	  equilibrium	  of	  folding	  toward	  more	  compact	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One	  explanation	  for	  how	  osmolytes	  shift	  the	  folding	  equilibrium	  is	  the	  mechanism	  of	  
molecular	  crowding,	  according	  to	  which,	  the	  restriction	  of	  protein	  conformations	  to	  allow	  
larger	  free	  volume	  for	  the	  added	  osmolytes	  destabilizes	  the	  unfolded	  state	  with	  respect	  to	  
the	  folded,	  functional	  conformation	  (12).	  In	  these	  CD	  experiments,	  the	  response	  to	  osmotic	  
stress	  was	   considered	   to	   be	   related	   to	   the	   hydration	   of	   the	  molecule.	   	   Osmotic	   pressure	  
causes	  some	  of	  the	  solute-­‐excluding	  waters	  to	  be	  released	  from	  the	  surface	  of	  the	  protein.	  
Information	   about	   the	   nature	   of	   physical	   interactions	   between	   macromolecules	   can	   be	  
gained	  from	  studying	  the	  dependence	  of	  ∆Nw	  on	  the	  chemical	  nature	  of	  the	  osmolytes	  and	  
the	  macromolecule’s	  surface	  (11).	  Many	  salts	  and	  polar	  solutes	  are	  preferentially	  excluded	  
from	  hydrophobic	  surfaces,	  and	  the	  number	  of	  preferentially	  bound	  waters	  depends	  on	  the	  
chemical	  nature	  and	  size	  of	   the	  osmolyte	  as	  well	  as	  on	  the	  nature	  of	   the	  macromolecular	  
surface	  (11).	  Changes	   in	   the	  number	  of	  preferentially	  bound	  water	  accompanying	   folding	  
and	  binding	   reactions	  were	  measured	   from	   the	   change	   in	  Δ!,	   the	   free	   energy	   of	   binding	  
with	  osmolyte	  concentration.	  For	  a	  constant	  difference	  in	  the	  number	  of	  included	  waters,	  it	  
was	  expected	  that	  ΔΔ!	  would	  vary	  linearly	  with	  solute	  osmotic	  pressure.	  (11).	  
For	  ACTR,	  NCBD,	  and	  NCBD/ACTR	  the	  ΔΔ!	  becomes	  more	  negative	  as	  the	  osmotic	  
pressure	   increases.	  As	  ΔΔ!	  is	  a	  measure	  of	  stability	  (8),	   the	  negative	   increase	   in	   its	  value	  
indicates	   that	   the	   peptide	   is	   more	   stable	   at	   higher	   osmotic	   pressures.	   	   Larger	   sized	  
osmolytes	  cause	  a	  leftward	  shift	  of	  the	  lines	  towards	  more	  negative	  ΔΔ!	  values,	  indicating	  
that	   larger	   osmolytes	   are	   better	   at	   stabilizing	   peptides.	   Figure	   8	   displays	   these	  
relationships	  for	  ACTR	  and	  NCBD/ACTR.	  Likewise,	  Δ!! 	  scales	  with	  the	  osmolyte	  molecular	  
volume,	  !!.	  It	  was	  expected	  that,	  Δ!! 	  would	  vary	  exponentially	  with	  partial	  molar	  volume,	  
and	  level	  off	  at	  the	  point	  where	  Δ!! 	  continues	  to	  increase	  even	  as	  molecular	  volume	  keeps	  
increasing.	   For	   small	   changes	   in	  molecular	   volume,	   it	  was	   expected	   to	   vary	   linearly.	   The	  
results	  are	  fit	  with	  an	  exponential	  curve,	  and	  the	  results	  do	  confirm	  the	  expected	  general	  
trend	   of	   an	   increase	   in	   the	   number	   of	   waters	   released	   as	   the	   molecular	   volume	   of	   the	  
osmolyte	  increases.	  It	  is	  notable	  that	  at	  the	  highest	  weight	  percent	  of	  PEG400,	  the	  complex	  
released	  4	  water	  molecules,	  comparable	  with	  the	  effect	  of	  EG	  on	  ACTR.	  	  
	  
	  
Fig	   8.	   The	   free	   energy	   of	   folding	   ΔG	   =	   –RTlnKeq,	   where	   Keq=[folded	   peptide]\[unfolded	  
peptide].	  ΔΔG	  is	  defined	  as	  the	  difference	  in	  the	  energy	  of	  the	  peptide’s	  folding	  between	  the	  
osmolyte	   solution	   and	  water:	  ΔΔG	   =ΔG(osmolyte)	   –	   	  ΔG(water).	   The	   numbers	   of	   waters	  
released	   from	   ACTR,	   DNw,	   depends	   on	   the	   osmolyte	   used.	   ΔNw	   scales	   with	   osmolyte	  
























     osmolyte Nw 
 ACTR, betaine              -3
 ACTR, EG   -3
 complex, PEG 400       -4
 ACTR, TEG   -9
 ACTR, xylitol -10
 ACTR, PEG 400 -17
	  
Figure	  9.	  Similar	  to	  ACTR,	  ΔΔG	  =ΔG(osmolyte)	  –	  	  ΔG(water).	  ΔNw,	  depends	  on	  the	  osmolyte	  




Figure	  10.	  The	  number	  of	  cosolute-­‐excluding	  waters	  released	  upon	  folding,	  ΔNw	  vs.	  Vm	  is	  
shown	   for	   both	   ACTR	   and	   NCBD.	   ΔNw,	   depends	   on	   the	   osmolyte	   used	   and	   scales	   with	  














     osmolyte Nw  
 EG   -5
 TEG -12
























Although	   this	   experiment	   provided	   insightful	   results,	   there	   are	   some	   limitations.	  	  
Due	   to	   time	   limitations	   the	   effects	   of	   varying	   pH	   were	   not	   fully	   explored	   and	   all	   CD	  
experiments	   were	   carried	   out	   in	   solutions	   of	   neutral	   pH.	   In	   future	   experiments,	   the	   CD	  
measurements	  could	  be	  repeated	  in	  solutions	  of	  varying	  pH.	  In	  fact,	  one	  experiment	  had	  to	  
be	   repeated	   because	   using	   TEG	   that	   had	   acidified	   due	   to	   improper	   storage	   produced	   an	  
interesting	  outlier	  in	  the	  ΔNw	  data;	  it	  was	  calculated	  that	  54	  waters	  had	  been	  released	  upon	  
folding	   in	   this	   experiment.	   Thus,	   changing	   the	   pH	   in	   addition	   to	   varying	   the	   osmotic	  
pressure	   has	   a	   strong	   effect	   on	   the	   secondary	   structure	   of	   these	   peptides.	   Another	  
limitation	  was	  the	  fact	  that	  the	  yields	  of	  the	  purified	  peptide	  were	  low.	  As	  a	  result,	  usually	  
the	   product	   from	   two	   purification	   rounds	   had	   to	   be	   combined	   to	   obtain	   one	   set	   of	   CD	  
measurements.	   However	   these	   limitations	   did	   not	   impact	   the	   results	   drastically,	   as	   the	  
results	  generally	  agree	  with	  the	  literature.	  
	  
Figure	  11.	  Purification	  run	  report.	  The	  fractions	  that	  were	  collected	  corresponded	  to	  the	  tip	  
of	  the	  peak.	  However,	  a	  great	  portion	  of	  the	  area	  under	  the	  curve	  corresponds	  to	  impurities	  
that	  likely	  occurred	  as	  a	  result	  of	  a	  messy	  peptide	  synthesis	  process.	  	  
	  
CONCLUSIONS	  
In	  order	  to	  accomplish	  their	  functions,	  most	  IDPs	  must	  undergo	  a	  disorder	  to	  order	  
transition	   (3).	   A	   lack	   of	   intrinsic	   structure	   and	   the	   capacity	   to	   fold	   into	   an	   ordered	  
conformation	   upon	   binding	   are	   advantageous	   because	   they	   confer	   upon	   IDPs	   high	  
specificity	  coupled	  with	  low	  affinity,	  the	  ability	  to	  bind	  to	  several	  different	  targets	  (one	  to	  
many	  signaling),	  and	  the	  capability	  to	  overcome	  steric	  restrictions	  (3).	  	  	  
Here	   it	   was	   found	   that	   osmotic	   stress	   caused	   the	   peptides	   to	   form	  more	  α-­‐helix	  
structures	  and	  to	  release	  waters.	  The	  osmolyte	  molecular	  volume	  was	  proportional	  to	  the	  
number	   of	  waters	   released.	   The	   osmolytes	   act	   by	   stabilizing	   the	  more	   compact,	   ordered	  
conformations	  of	  the	  peptide	  and	  cause	  water	  molecules	  associated	  with	  the	  surface	  of	  the	  
peptide	  to	  be	  released.	   	  Also,	   in	  most	  cases,	  the	  linear	  free	  energy	  change	  with	  osmolality	  
includes	   the	   initial,	   zero	  osmolyte	   condition	  at	  ΔΔG	  =	  0.	  This	   is	  most	   easily	  observed	   for	  
NCBD	   (Fig.	   9)	   and	   indicates	   that	   the	   variation	   in	   secondary	   structure	   by	   the	   added	  
osmolyte	  is	  due	  to	  osmotic	  effects	  and	  not	  by	  any	  preferential	  interactions	  between	  peptide	  
and	  osmolyte.	  The	  one	  exception	  appears	  to	  be	  ACTR	  with	  EG,	  where	  repeat	  measurements	  
confirmed	   the	  particular	   free	   energy	   variation	   observed.	  Here,	   it	   does	   seem	   that	   specific	  
interactions	  by	  EG	  have	  altered	   the	   initial	   state	  of	  ACTR.	   Interestingly,	  EG	  does	  not	  have	  
strong	  preferential	  interaction	  with	  NCBD.	  These	  subtle	  features	  of	  EG	  as	  an	  osmolyte	  for	  
these	  IDPs	  deserve	  further	  study	  to	  fully	  understand	  EG	  action.	  	  
It	  is	  notable	  that	  even	  the	  complex	  was	  able	  to	  fold	  into	  a	  structure	  containing	  more	  
α-­‐helix.	  Because	  the	  amino	  acids	  that	  have	  formed	  α-­‐helices	  in	  the	  bound	  form	  locked	  into	  
their	  conformations,	  and	  thus	  cannot	  be	  induced	  to	  fold	  any	  further,	  the	  extra	  α-­‐helices	  that	  
formed	  were	  probably	  formed	  in	  the	  flexible	  tail	  of	  ACTR	  that	  was	  not	  bound	  to	  NCBD.	  This	  
flexible	  tail	  is	  characterized	  as	  an	  additional	  N-­‐terminal	  leucine-­‐rich	  motif	  located	  between	  
residues	   1029	   -­‐	   1,033	   that	   does	   not	   participate	   in	   the	   hydrophobic	   core	   and	   remains	  
disordered	   in	   the	   complex	   but	   rather	   is	   available	   to	   interact	   with	   other	   proteins	   (13). 
These	  hydrophobic	   leucine	   regions	  are	   significant	  because	   the	  molecular	   interface	  of	   the	  
ACTR	  binding	  domains	  consist	  of	  clusters	  of	  hydrophobic	  residues	  separated	  by	  regions	  of	  
polar	   amino	   acids	   rich	   in	   glycine,	   serine,	   proline,	   or	   glutamine.	   In	   ACTR	   and	   CBP,	   the	  
interaction	  clusters	  form	  recognizable	  motifs	  with	  sequence	  patterns	  f-­‐X-­‐X-­‐f-­‐f,	  f-­‐f-­‐X-­‐X-­‐f	  or	  a	  
combination	   of	   the	   two,	   where	   f	   is	   a	   bulky	   hydrophobic	   residue	   (13).	   Many	   of	   these	  
hydrophobic	  motifs	  are	   rich	   in	   leucine,	  and	   they	  may	   function	  similarly	   to	   the	  L-­‐X-­‐X-­‐L-­‐	  L	  
motifs	   that	   are	   responsible	   for	   the	   interactions	   between	   the	   p160	   coactivators	   and	   the	  
ligand-­‐binding	   domains	   of	   nuclear	   receptors	   (13).	   However,	   while	   the	   L-­‐X-­‐X-­‐L-­‐L	   motifs	  
form	  an	  isolated	  helix	  upon	  binding	  to	  a	  structured	  nuclear	  receptor	  ligand-­‐binding	  domain,	  
the	   disordered	   leucine-­‐rich	   motifs	   in	   the	   ACTR	   and	   CBP	   binding	   domains	   undergo	  
synergistic	  folding	  to	  form	  the	  binding	  interface	  (13).	  	  
	   There	  are	  two	  competing	  models	  that	  attempt	  to	  explain	  protein	  association	  reactions	  
that	   involve	  binding	  and	   folding.	  One	  model	   is	   the	   induced	   fit	  model	  and	   the	  other	   is	   the	  
conformational	  selection	  model	  (14).	  According	  to	  the	  induced	  fit	  model,	  the	  protein	  binds	  
or	   associates	   with	   its	   ligand	   in	   a	   fully	   disordered	   state	   and	   then	   undergoes	   the	  
conformational	  change	   (folding)	   (2,14).	  According	   to	   the	  conformational	   selection	  model,	  
the	  bound-­‐state	  conformation	  must	  exist	  in	  the	  free	  ensemble,	  previous	  to	  binding,	  and	  one	  
partially	  prefolded	  ligand	  selectively	  associates	  with	  its	  partially	  prefolded	  binding	  partner.	  	  
According	   to	   the	   conformational	   selection	   model,	   NCBD	   would	   adopt	   a	   conformation	  
similar	   to	   that	   in	   the	   complex	   with	   ACTR	   as	   it	   is	   associating	   with	   ACTR.	   NMR	   results	  
confirm	  that	  conformational	  selection	  plays	  an	  important	  role	  in	  this	  interaction	  (2).	   
Literature	  results	  show	  that	  the	  conformation	  of	  NCBD	  in	  the	  complex	  with	  ACTR	  is	  
present	  even	   in	   the	  absence	  of	  ACTR	  (2).	  Although	  they	  do	  not	  provide	  an	  answer	   to	   the	  
debate	   between	   the	   induced	   fit	   model	   and	   the	   conformational	   selection	   model,	   these	  
current	   experiments	   confirm	   the	   fact	   that	  NCBD	  and	  ACTR	   can	  be	   induced	   to	   fold	   in	   the	  
absence	   of	   their	   binding	   partners	   and	   thus	   support	   the	   existence	   of	   structured	   NCBD	  
molecules	  implies	  a	  conformational	  selection	  mechanism	  in	  which	  ACTR	  selectively	  binds	  
to	   the	   fraction	   of	   the	   prefolded	   ACTR	   binding	   conformation	   of	   the	   NCBD	   ensemble	   (2).	  
Disordered	   proteins	   and	   regions	   are	   required	   for	   transcriptional	   activators,	   signaling	  
proteins,	   and	   regulatory	   proteins	   to	   function.	   However,	   they	   are	   also	   the	   sites	   of	   many	  
chromosomal	   translocations	   result	   in	   disease	   (1).	   For	   example,	   translocations	   that	   fuse	  
regions	  of	  CBP	  or	  p300	  to	  segments	  of	  MOZ	  (the	  monocytic	  zync-­‐finger	  leukemia	  protein)	  
or	  MLL	  are	  associated	  with	  leukemia	  in	  humans.	  Translocations	  within	  disordered	  regions	  
leave	  the	  folded	  domains	  intact	  and	  produce	  fusion	  proteins	  with	  abnormal	  functions	  (2).	  
In	   contrast,	   truncations	   or	   translocations	   of	   gene	   regions	   that	   include	   fully	   structured	  
domains	  would	   lead	   to	   the	  production	  of	  a	  misfolded	  protein	   that	  would	  be	  degraded	  by	  
the	  cellular	  machinery	  quickly	  enough	  to	  avoid	  producing	  disease	  (2).	  	  
The	  conformational	  flexibility	  of	  IDPs	  gives	  them	  the	  functional	  versatility	  needed	  to	  
bind	  to	  and	  recognize	  a	  diverse	  array	  of	  other	  proteins,	  RNA,	  DNA,	  and	  other	  small	  ligands	  
(15).	   However,	   disordered	   regions	   are	   also	   involved	   in	   the	   promotion	   of	  
neurodegenerative	  protein	  folding	  diseases	  such	  as	  Parkinson’s	  and	  Huntington’s	  diseases	  
and	   prion	   diseases	   (2).	   	   	   For	   example,	   human	   CBP,	   which	   contains	   a	   stretch	   of	   19	   Gln	  
residues,	   can	   potentially	   be	   sequestered	   in	   polyglutamine	   aggregates	   in	   the	   brains	   of	  
patients	  with	  Huntington’s	  disease	  and	  it	  has	  been	  proposed	  that	  the	  disease	  might	  result	  
from	  interference	  with	  the	  normal	  transcriptional	  functions	  of	  CBP	  (2).	  Accordingly,	  it	  has	  
been	   shown	   that	   the	   MET-­‐16	   peptide	   can	   fold	   into	   a	   stable	   monomeric	   β-­‐hairpin	  
conformation	  under	  some	  conditions,	  while	  under	  others	  it	  aggregates	  into	  amyloid	  fibers	  
(16).	  In	  the	  presence	  of	  polyols	  and	  polyethylene	  glycols	  acting	  as	  excluded	  cosolutes,	  the	  
monomeric	  β-­‐hairpin	  conformation	  was	  stabilized	  with	  respect	  to	  the	  unfolded	  state	  (16).	  
Just	  as	   this	  osmolyte	  study	  demonstrates,	   it	  was	  also	   found	   that	  stabilization	   free	  energy	  
varied	   linearly	   with	   osmolyte	   concentration	   and	   grew	  with	  molecular	   volume	   (16).	   The	  
reaction	  that	  was	  studied	  was	  related	  to	  amyloid	  aggregation,	  which	  is	  the	  form	  of	  protein	  
self-­‐oligomerization	   that	   is	   implicated	   in	   the	   formation	   of	   several	   neurodegenerative	  
diseases	   (16).	   	   A	   recent	   survey	   found	   that	   human	  proteins	   that	   have	  numerous	   tracts	   of	  
extremely	  low	  complexity	  and	  features	  characteristic	  of	  IDPs,	  most	  commonly	  consisting	  of	  
Gln,	  Ser,	  or	  acidic	  residues,	  are	  often	  associated	  with	  neurological	  diseases	  and	  cancer	  (2).	  
Thus,	   further	   study	   into	   structure-­‐function	   relationship	  of	   IDPs	  may	  provide	   information	  
about	  the	  mechanisms	  of	  neurodegenerative	  disease	  processes.	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